CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases. Our team has over 20 years’ experience in oncology and molecular cell biology and are using our expertise and experience in these areas to develop novel innovative treatments that will enhance the effectiveness of standard-of-care therapies in oncology and other inflammatory conditions.
CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to enhance the effectiveness of the most widely used, standard-of-care therapies and to improve the lives of patients with cancer and inflammatory diseases.
Belfast, UK. 5th January, 2021. CV6 Therapeutics, a drug development company focussed on the development and commercialisation of novel combination therapeutics for cancer and inflammatory diseases, have been featured in the November 2020 special report on the ‘12 Clusters of Tech’, a national campaign to champion leading clusters of UK technology led by the UK Tech Cluster […]Find Out More